Abcellera Biologics Inc.

This early-stage trial tests a new biologic drug called ABCL635 for moderate-to-severe hot flashes in postmenopausal women. The study first checks safety in healthy volunteers, then measures how well the drug reduces hot flash frequency and severity. About 136 people will take pa…

This early-stage study tests the safety of a new drug called ABCL575 in 40 healthy adults. Participants receive either a single dose of the drug or a placebo. The goal is to check for side effects and how the body processes the drug, not to treat any disease.